A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

NCT06873815 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Extramammary Paget's Disease

Interventions

DRUG: Fluorescein Sodium

Sponsor

Memorial Sloan Kettering Cancer Center